Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment.
about
miR-126 regulates angiogenic signaling and vascular integrityExciting new advances in neuro-oncology: the avenue to a cure for malignant gliomaThe Foxc2 transcription factor regulates tumor angiogenesisThe role of pericytes in blood-vessel formation and maintenanceMolecular biology of gliomas: present and future challengesDevelopmental and pathological angiogenesis in the central nervous systemVascular endothelial growth factor and kinase domain region receptor are involved in both seminiferous cord formation and vascular development during testis morphogenesis in the ratSynthetic and Biological Studies of Sesquiterpene Polygodial: Activity of 9-Epipolygodial against Drug-Resistant Cancer CellsHigh interstitial fluid pressure - an obstacle in cancer therapyAngiogenic inhibition in high-grade gliomas: past, present and future.Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte contentThe role of myosin II in glioma invasion of the brain.E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B.Advanced magnetic resonance imaging of the physical processes in human glioblastoma.The effects of tumor-derived platelet-derived growth factor on vascular morphology and function in vivo revealed by susceptibility MRI.Phase II study of sunitinib malate in head and neck squamous cell carcinoma.Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomasPlatelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas.Molecular mediators of angiogenesis.Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesisMolecular targeting of glioblastoma: Drug discovery and therapiesMalignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signalingPleiotropic stromal effects of vascular endothelial growth factor receptor 2 antibody therapy in renal cell carcinoma models.A multi-parametric imaging investigation of the response of C6 glioma xenografts to MLN0518 (tandutinib) treatment.Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escapeUp-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma.Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models.Angiogenesis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables.Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.Comparative transcriptomics reveals similarities and differences between astrocytoma grades.Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma.Emerging insights into the molecular and cellular basis of glioblastoma.Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma.Wittig derivatization of sesquiterpenoid polygodial leads to cytostatic agents with activity against drug resistant cancer cells and capable of pyrrolylation of primary aminesPlGF-induced VEGFR1-dependent vascular remodeling determines opposing antitumor effects and drug resistance to Dll4-Notch inhibitors.Tyrphostin AG 1296 induces glioblastoma cell apoptosis in vitro and in vivo.Angiogenesis in gliomas: biology and molecular pathophysiology.Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.Mechanisms of angiogenesis in gliomas.
P2860
Q24569770-ED196C8F-23F1-4747-B9FB-0F8E2568E05EQ24632791-8391289B-9E87-4C4F-9F08-3D26E4C8431DQ24647592-E963BBB7-93E6-40C3-856A-D5F83B88F120Q24683881-1F5CC128-EA1E-4309-B5B0-1BC087CB888EQ27001295-2C238ED4-95DD-478E-9CF4-AC55C99C69D2Q27023250-6E53D746-738E-4B5D-BD30-05FDC5E6174DQ28570072-16F75517-3467-4D4B-AAD5-0544BC0824A4Q28834689-B19EE0AE-EEA8-447A-8B4C-0BF7981559B0Q29619719-D6F66B88-0C81-4313-BCD7-E4CBE53AC75AQ30455596-E0F9F27B-4386-481D-B833-780801EEEB76Q30479724-A91284D2-9945-4120-821F-FBB0F7219B27Q30482874-0439A4B4-BC23-4614-9E4B-FCE9D1B9002AQ30564026-E393DC7A-AB16-4B2B-90BE-3A5AFEA0CD92Q30847284-21506497-C9F7-44D1-B144-00BC45602095Q33306932-4EBC9307-425E-46AA-9545-1A2F900C6C6DQ33385634-E6895228-BA04-4D30-9C76-A7B218FCBA06Q33388438-D8F5DEA2-7B60-4D9D-8305-77B39D709412Q33597254-2502A4D8-2D19-47F6-A8EE-48612C64A1ECQ33609232-81D05853-76F8-4A5D-A3E4-C7DF959EFD83Q33639474-E0C2E107-E7C0-4C07-83E0-ACBE8302F71FQ33836078-C0B603BF-F4EA-435B-A8EE-3386F5E100B0Q33911283-C43F6EA4-D112-4F9F-BD5F-2B55977EABFBQ34309316-C5AAE35D-0443-4F76-AD2D-D11D20FCDA0DQ34497997-A20DA190-A403-4FEC-A49D-A76E93D44701Q34702261-885C0768-5BB9-4C7E-9B93-63CEDD250C4AQ34783533-36170C6A-EF24-4B3D-8138-56631164CC13Q35083735-4B91E662-2B7B-42D9-A653-2A4ADB4EBBFDQ35163538-F7BCE515-09AF-4D0C-999F-B65F8E1A697EQ35257111-8D65C45C-5993-4157-9E99-1358239F8C87Q35440540-8AFD3272-20A8-45B2-82C7-B26587151622Q35870174-A7036EB4-06C7-4276-8F4F-12C68B180E4EQ35895174-509EB3F5-CB1D-472B-8446-929792E3A8CDQ35914897-328CEB82-3D90-489D-B47F-59D649499363Q36013325-DDC2D77D-AEDE-4AD6-811C-415812E43970Q36198988-07516991-C956-4909-98C7-3B71A0F55832Q36268182-FE0730D7-5B43-42C1-A3C9-A2DF16F922E4Q36334429-E410E662-7257-4BB6-83E1-4D2CAF60AC18Q36359221-2FB1C630-5E02-4E23-ACF0-F00085BD7FEFQ36413901-8BA269E0-5C69-4953-BE84-EAF4231F9015Q36429021-1963B4D5-6ABC-4AA1-A9FC-7A533948720B
P2860
Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Platelet-derived growth factor ...... romoting pericyte recruitment.
@en
type
label
Platelet-derived growth factor ...... romoting pericyte recruitment.
@en
prefLabel
Platelet-derived growth factor ...... romoting pericyte recruitment.
@en
P2093
P2860
P1476
Platelet-derived growth factor ...... romoting pericyte recruitment.
@en
P2093
Degui Wang
Hui-Jen Su Huang
Shi-Yuan Cheng
Webster K Cavenee
Weisong Gu
P2860
P304
P356
10.1016/S0002-9440(10)63905-3
P407
P577
2003-04-01T00:00:00Z